Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | FAAH | O00519 | 2/20 | 0.45 |
| ▸ | DGKA | P23743 | 1/20 | 0.42 |
| ▸ | CES2 | O00748 | 4/20 | 0.41 |
| ▸ | CES1 | P23141 | 4/20 | 0.41 |
| ▸ | TSHR | P16473 | 4/20 | 0.41 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.40 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | PAM | P19021 | 2/20 | 0.39 |
| ▸ | PPARG | P37231 | 4/20 | 0.39 |
| ▸ | PPARD | Q03181 | 4/20 | 0.39 |
| ▸ | PPARA | Q07869 | 4/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.39 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.39 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.39 |
| ▸ | TLR2 | O60603 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2954948 | 1.00 | NPSR1 (0.47) | NPSR1FAAHDGKACES2CES1 | |
| SCHEMBL15375163 | 1.00 | NPSR1 (0.47) | NPSR1FAAHDGKACES2CES1 | |
| SCHEMBL3360702 | 0.98 | FAAH (0.47) | NPSR1FAAHDGKACES2CES1 | |
| SCHEMBL15482689 | 0.98 | FAAH (0.47) | NPSR1FAAHDGKACES2CES1 | |
| SCHEMBL2838004 | 0.98 | FAAH (0.47) | NPSR1FAAHDGKACES2CES1 | |
| SCHEMBL13468257 | 0.98 | FAAH (0.47) | NPSR1FAAHDGKACES2CES1 | |
| SCHEMBL6524315 | 0.98 | FAAH (0.47) | NPSR1FAAHDGKACES2CES1 | |
| SCHEMBL7709678 | 0.98 | FAAH (0.47) | NPSR1FAAHDGKACES2CES1 | |
| SCHEMBL13129941 | 0.98 | FAAH (0.47) | NPSR1FAAHDGKACES2CES1 | |
| SCHEMBL7709682 | 0.98 | FAAH (0.47) | NPSR1FAAHDGKACES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100254927-A1 | OLFACTORY ADAPTATION AND CROSS-ADAPTING AGENTS TO REDUCE THE PERCEPTION OF BODY ODORS | MONELL CHEMICAL SENSES CENTER (US) | 2010-10-07 | — | — | US | claimed |
| EP-1474095-A4 | OLFACTORY ADAPTATION AND CROSS-ADAPTING AGENTS TO REDUCE THE PERCEPTION OF BODY ODORS | MONELL CHEMICAL SENSES CENTRE (US) | 2007-11-28 | — | — | EP | claimed |
| US-20070020210-A1 | Methods of reducing the perception of body odors with olfactory adaptation and cross-adapting agents | MONELL CHEMICAL SENSES CENTER | 2007-01-25 | — | — | US | claimed |
| EP-1474095-A1 | OLFACTORY ADAPTATION AND CROSS-ADAPTING AGENTS TO REDUCE THE PERCEPTION OF BODY ODORS | MONELL CHEMICAL SENSES CENTER (US) | 2004-11-10 | — | — | EP | claimed |
| US-20030152538-A1 | Olfactory adaptation and cross-adapting agents to reduce the perception of body odors | SYMRISE INC. | 2003-08-14 | — | — | US | claimed |
| WO-2003061609-A1 | OLFACTORY ADAPTATION AND CROSS-ADAPTING AGENTS TO REDUCE THE PERCEPTION OF BODY ODORS | MONELL CHEMICAL SENSES CENTER (US) | 2003-07-31 | — | — | WO | claimed |
| CN-113710687-A | Cyclopeptide antibiotics | 豪夫迈·罗氏有限公司 | 2021-11-26 | — | — | CN | disclosed |
| US-20210009922-A1 | METHODS AND COMPOSITIONS FOR REDUCING PERSISTENT ODOR IN CLOTHING AND MITIGATING BIOFILMS | WELLS FARGO BANK, N.A. | 2021-01-14 | — | — | US | disclosed |
| CN-111148739-A | Cyclopeptide antibiotics | 豪夫迈·罗氏有限公司 | 2020-05-12 | — | — | CN | disclosed |
| EP-1474095-B2 | OLFACTORY ADAPTATION AND CROSS-ADAPTING AGENTS TO REDUCE THE PERCEPTION OF BODY ODORS | MONELL CHEMICAL SENSES CENTRE (US) | 2016-12-21 | — | — | EP | disclosed |
| EP-3089730-A1 | DEODORANT COMPOSITIONS HAVING ANTIBACTERIAL AND ODOR BLOCKING PROPERTIES AND RELATED METHODS | The Dial Corporation (US) | 2016-11-09 | — | — | EP | disclosed |
| US-9381142-B2 | Olfactory adaptation and cross-adapting agents to reduce the perception of body odors | MONELL CHEMICAL SENSES CENTER (US) | 2016-07-05 | — | — | US | disclosed |
| WO-2015102915-A1 | DEODORANT COMPOSITIONS HAVING ANTIBACTERIAL AND ODOR BLOCKING PROPERTIES AND RELATED METHODS | THE DIAL CORPORATION (US) | 2015-07-09 | — | — | WO | disclosed |
| US-20100035948-A1 | Furanone compounds and lactam analogues thereof | UNILEVER PLC (GB) | 2010-02-11 | — | — | US | disclosed |
| WO-2008040097-A1 | FURANONE COMPOUNDS AND LACTAM ANALOGUES THEREOF | BIOSIGNAL LIMITED (AU) | 2008-04-10 | — | — | WO | disclosed |
| EP-1474095-A4 | OLFACTORY ADAPTATION AND CROSS-ADAPTING AGENTS TO REDUCE THE PERCEPTION OF BODY ODORS | MONELL CHEMICAL SENSES CENTRE (US) | 2007-11-28 | — | — | EP | disclosed |
| US-20070020210-A1 | Methods of reducing the perception of body odors with olfactory adaptation and cross-adapting agents | MONELL CHEMICAL SENSES CENTER | 2007-01-25 | — | — | US | disclosed |
| EP-1474095-A1 | OLFACTORY ADAPTATION AND CROSS-ADAPTING AGENTS TO REDUCE THE PERCEPTION OF BODY ODORS | MONELL CHEMICAL SENSES CENTER (US) | 2004-11-10 | — | — | EP | disclosed |
| US-20030152538-A1 | Olfactory adaptation and cross-adapting agents to reduce the perception of body odors | SYMRISE INC. | 2003-08-14 | — | — | US | disclosed |
| WO-2003061609-A1 | OLFACTORY ADAPTATION AND CROSS-ADAPTING AGENTS TO REDUCE THE PERCEPTION OF BODY ODORS | MONELL CHEMICAL SENSES CENTER (US) | 2003-07-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100035948-A1 | Furanone compounds and lactam analogues thereof | FDPS, CYP2C19, MRPL21 | NPSR1 3097/4885FAAH 908/4885DGKA 4436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.